title: Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions.
abstract: Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are characterised by high-protein pulmonary edema and severe hypoxaemic respiratory failure due to increased permeability of pulmonary microvascular endothelial cells (PMVEC). Alveolar epithelial cells (AEC) contribute importantly to normal alveolar function, and AEC dysfunction in ALI/ARDS is associated with worse outcomes. We hypothesized that AEC can modulate human PMVEC barrier function, and investigated the effects of AEC presence on human PMVEC barrier under septic conditions in vitro. PMVEC isolated from human lung were treated in vitro with septic stimulation (lipopolysaccharide [LPS], a mixture of clinically-relevant cytokines [cytomix], or plasma from patients with severe sepsis), and the trans-PMVEC leak of Evans Blue dye-labeled albumin assessed. PMVEC septic responses were compared in the presence/absence of co-cultured A549 epithelial cell line or primary human AEC. Septic stimulation with LPS, cytomix, or septic plasma induced marked PMVEC hyper-permeability (10.2±1.8, 8.9±2.2, and 3.7±0.2 fold-increase vs. control, respectively, p<0.01 for all). The presence of A549 cells or primary human AEC in a non-contact co-culture model attenuated septic PMVEC hyper-permeability by 39±4% to 100±3%, depending on the septic stimulation (p<0.05). Septic PMVEC hyper-permeability was also attenuated following treatment with culture medium conditioned by previous incubation with either naïve or cytomix-treated A549 cells (p<0.05), and this protective effect of A549 cell-conditioned medium was both heat-stable and transferable following lipid extraction. Cytomix-stimulated PMN-dependent PMVEC hyper-permeability and trans-PMVEC PMN migration were also inhibited in the presence of A549 cells or A549 cell-conditioned medium (p<0.05). Human AEC appear to protect human PMVEC barrier function under septic conditions in vitro, through release of a soluble mediator(s), which are at least partly lipid in nature. This study suggests a scientific and potential clinical therapeutic importance of epithelial-endothelial cross talk in maintaining alveolar integrity in ALI/ARDS.
authors: Centre for Critical Illness Research, Division of Respirology, Lawson Health Research Institute, London Health Sciences Center, London, Ontario, Canada.
authors: Lefeng
authors: L
authors: Wang
authors: Ravi
authors: R
authors: Taneja
authors: Wei
authors: W
authors: Wang
authors: Li-Juan
authors: LJ
authors: Yao
authors: Ruud A W
authors: RA
authors: Veldhuizen
authors: Sean E
authors: SE
authors: Gill
authors: Dalilah
authors: D
authors: Fortin
authors: Richard
authors: R
authors: Inculet
authors: Richard
authors: R
authors: Malthaner
authors: Sanjay
authors: S
authors: Mehta
mesh_terms: D002199:Capillary Permeability / Q000502:physiology*; D002448:Cell Adhesion / Q000502:physiology; D002460:Cell Line; D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D018920:Coculture Techniques; D042783:Endothelial Cells / Q000166:cytology / Q000502:physiology*; D006801:Humans; D042361:Mammary Glands, Human / Q000166:cytology*; D009504:Neutrophils / Q000166:cytology / Q000378:metabolism; D018805:Sepsis / Q000378:metabolism / Q000473:pathology*
references: Cell Tissue Res. 2009 Apr;336(1):91-105
references: 19238447
references: Trends Immunol. 2009 Nov;30(11):547-56
references: 19783480
references: Am J Respir Cell Mol Biol. 2005 Apr;32(4):262-7
references: 15618437
references: J Appl Physiol Respir Environ Exerc Physiol. 1979 Dec;47(6):1315-24
references: 536303
references: Annu Rev Pathol. 2009;4:71-95
references: 18754744
references: Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L20-2
references: 21551081
references: Crit Care Med. 1996 Nov;24(11):1782-6
references: 8917025
references: Am J Respir Crit Care Med. 2004 Oct 1;170(7):766-72
references: 15201135
references: Clin Chest Med. 2000 Sep;21(3):435-66
references: 11019719
references: Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1035-41
references: 19700643
references: Nat Rev Immunol. 2005 Jan;5(1):58-68
references: 15630429
references: Physiol Rev. 2003 Apr;83(2):309-36
references: 12663861
references: FASEB J. 2005 Oct;19(12):1646-56
references: 16195373
references: Crit Care Med. 2005 Jun;33(6):1333-9
references: 15942352
references: Shock. 2012 May;37(5):539-47
references: 22392143
references: J Natl Cancer Inst. 2007 Sep 5;99(17):1313-27
references: 17728215
references: Respir Physiol Neurobiol. 2007 Dec 15;159(3):350-9
references: 17604701
references: Expert Rev Clin Immunol. 2009 Jan 1;5(1):63-75
references: 19885383
references: Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H1-H10
references: 11123211
references: Mol Med. 2011 Mar-Apr;17(3-4):293-307
references: 21046059
references: Am J Physiol Lung Cell Mol Physiol. 2012 Feb 1;302(3):L275-86
references: 21964402
references: Respirology. 2006 Jan;11 Suppl:S12-5
references: 16423262
references: N Engl J Med. 2000 May 4;342(18):1334-49
references: 10793167
references: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1057-62
references: 14630629
references: Expert Rev Respir Med. 2011 Feb;5(1):115-26
references: 21348592
references: Annu Rev Pathol. 2011;6:147-63
references: 20936936
references: Mol Cancer Res. 2009 Mar;7(3):393-401
references: 19240180
references: Methods Mol Med. 2005;107:207-16
references: 15492374
references: Chest. 1992 Jun;101(6):1481-3
references: 1600757
references: Am J Respir Crit Care Med. 2004 Aug 1;170(3):227-33
references: 15059787
references: J Pathol. 2004 Feb;202(2):145-56
references: 14743496
references: Respir Physiol Neurobiol. 2010 Aug 31;173 Suppl:S43-54
references: 20433956
references: Chest. 2007 Feb;131(2):554-62
references: 17296661
references: Am J Respir Cell Mol Biol. 2004 Apr;30(4):500-9
references: 15033639
references: Microvasc Res. 2006 Jan;71(1):40-7
references: 16376951
references: Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1164-72
references: 16414981
references: Am J Respir Crit Care Med. 2002 Jun 15;165(12):1634-9
references: 12070065
references: Am J Respir Cell Mol Biol. 2007 Apr;36(4):497-503
references: 17099142
references: Exp Lung Res. 2006 Nov-Dec;32(10):455-82
references: 17169854
references: Microvasc Res. 2007 Jul;74(1):23-31
references: 17451752
references: J Immunol. 2007 Jan 1;178(1):463-73
references: 17182585
references: Microvasc Res. 2008 Aug;76(2):80-8
references: 18616952